Glaxo for now Saudi's sole supplier of H1N1 vaccine
RIYADH, Nov 7 (Reuters) - British drugmaker GlaxoSmithKline (GSK.L: Quote, Profile, Research) is currently Saudi Arabia's sole supplier of a vaccine for the H1N1 flu virus, the health ministry spokesman said on Saturday.
"For the moment, the only vaccine that has been authorised is the GlaxoSmithKline vaccine Pandemrix," health ministry spokesman Khaled Mirghalani told Reuters.
"We will in the future get vaccines from other clients, from other companies as soon as they get approved by the SFDA (Saudi Food and Drug Authority)," he said.
(Reporting by Nael Shyoukhi, writing by Raissa Kasolowsky; Editing by Sanjeev Miglani)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India during the Reuters India Investment Summit in Mumbai and Bangalore. Full Coverage | Blog
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
